"Phase 3" News and Videos   LIVE

ℹ️ This is a LIVE page which updates automatically as we're monitoring our hand-curated selection of verified and trustworthy media outlets
Shanghai, China — March 28, 2024 — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the..
Credit: EQS Group - Published 21 hours ago

Lok Sabha elections 2024: The elections will be held in five phases. 5 seats in Phase 1 (April 19), 8 seats in Phase 2 (April 26), and 11 seats each in Phase 3..
Credit: Mid-Day - Published 3 days ago

Shanghai, China – March. 20, 2024 — Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery,..
Credit: EQS Group - Published 1 week ago

Phase 1 will be held on April 19, Phase 2 on April 26, Phase 3 on May 7, Phase 4 on May 13, Phase 5 on May 20, Phase 6 on May 25, and Phase 7 on June 1.
Credit: DNA - Published 2 weeks ago

A teenager caused a fatal car crash in Mayur Vihar Phase 3. The 17-year-old driver was arrested. His friend, a passenger, is on the run. The vehicle owner is..
Credit: IndiaTimes - Published 2 weeks ago

-- Macau is on course to become the first of Everest’s Asian territories to get etrasimod approval
-- Can provide access to patients in China’s Greater..
Credit: EQS Group - Published 3 weeks ago

--VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU--Shanghai, China –..
Credit: EQS Group - Published on February 22, 2024

--Cefepime-taniborbactam was superior to meropenem for the composite efficacy endpoint with composite efficacy sustained at late follow-up visit--Shanghai,..
Credit: EQS Group - Published on February 20, 2024

Shanghai, China – Dec. 27, 2023 — Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development,..
Credit: EQS Group - Published on December 26, 2023

Shanghai, China – Dec. 21, 2023 — Everest Medicines (HKEX 1952.HK, "Everest", or the "Company”)’s licensing partner Calliditas Therapeutics AB (Nasdaq:..
Credit: EQS Group - Published on December 21, 2023

--Clinically meaningful and statistically significant results demonstrated for primary endpoint and key secondary endpoints for the 12-week induction period..
Credit: EQS Group - Published on November 30, 2023

*Shanghai, China – Nov. 30, 2023 —* Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development,..
Credit: EQS Group - Published on November 29, 2023

--Nefecon® is the first approved medicine with an IgAN indication in China--

--The approval marks a new era of IgAN treatment for Chinese..
Credit: EQS Group - Published on November 24, 2023

Sun Pharmaceuticals reported a 5% increase in its consolidated net profit for the second quarter of FY 2024. The company's revenue also rose by 11.3% and its..
Credit: IndiaTimes - Published on November 1, 2023

A male contraceptive is closer to becoming a reality as a non-hormonal injectable has cleared phase-3 trials, according to the Indian Council of Medical..
Credit: IndiaTimes - Published on October 30, 2023

Shanghai, China —Oct. 27, 2023 — Everest Medicines (HKEX 1952.HK, “Everest,” or the “Company”), a biopharmaceutical company focused on the..
Credit: EQS Group - Published on October 27, 2023

Shanghai, China—Oct. 16, 2023 — Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Pfizer Inc. (NYSE: PFE) has received approval..
Credit: EQS Group - Published on October 15, 2023

Shanghai, China — Oct. 5, 2023 — Everest Medicines’ (HKEX 1952.HK, “Everest”, or the "Company”) partner Calliditas Therapeutics AB (Nasdaq: CALT,..
Credit: EQS Group - Published on October 4, 2023

Shanghai, China — Sept. 21, 2023 — Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the development,..
Credit: EQS Group - Published on September 21, 2023

Shanghai, China — Sept. 20, 2023 — Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing, manufacturing, and commercializing..
Credit: EQS Group - Published on September 20, 2023

*KRBL Limited*s India Gate Basmati Rice, the Worlds No.1 Basmati rice brand and a pioneer in packaged Basmati, continues to champion purity and authenticity with..
Credit: NewsVoir - Published on September 19, 2023

Shanghai, China – August 24, 2023 – Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the..
Credit: EQS Group - Published on August 24, 2023

Shanghai, China — August 21, 2023 — Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company") announced today that U.S. Food and Drug Administration..
Credit: EQS Group - Published on August 21, 2023

Shanghai, China — August 18, 2023 — Everest Medicines’ (HKEX 1952.HK, “Everest”, or the "Company") partner Calliditas Therapeutics AB (Nasdaq: CALT,..
Credit: EQS Group - Published on August 18, 2023

Shanghai, China—August 15, 2023 — Everest Medicines (HKEX 1952.HK)’s partner Venatorx Pharmaceuticals announced that the U.S. Food and Drug Administration..
Credit: EQS Group - Published on August 15, 2023

Shanghai, China —August 1, 2023 — Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the development,..
Credit: EQS Group - Published on August 1, 2023

TS DOST Phase 3 Allotment Result 2023: Candidates can check the result through the official site of TS DOST at dost.cgg.gov.in.
Credit: DNA - Published on July 21, 2023

India's first Pet-Ed startup thePack.in, in collaboration with Tara Chand Infralogistic Solutions Limited introduces the first-of-its-kind "Yard Guards Project,"..
Credit: NewsVoir - Published on July 12, 2023

Shanghai, China — June 21, 2023 — Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company") announced today that its partner Calliditas Therapeutics..
Credit: EQS Group - Published on June 21, 2023

The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vaccine to be..
Credit: IndiaTimes - Published on June 12, 2023

A 30-year-old man has been arrested after his wife was found dead at their residence in Noida on Wednesday. The woman's family alleged that they were being..
Credit: IndiaTimes - Published on June 8, 2023

Delhi Metro: Train services on Phase 3 sections usually begin at 8 am on Sundays.
Credit: DNA - Published on May 27, 2023

Shanghai, China —May 17, 2023 — Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the development,..
Credit: EQS Group - Published on May 17, 2023

The Intellectual Property Office of Vietnam (IPVN), according to Notice No. 8617/TB-SHTT dated 28 September 2022, has just informed: "From 1 October 2022 to 31..
Credit: Mondaq - Published on May 13, 2023

The third phase of the 16th edition of BAJA SAEINDIA commenced on the 5th of April, 2023 Chitkara University, Baddi, Himachal Pradesh. Over 180 teams from 23..
on April 5, 2023 • NewsVoir
*IndiaLand*, a company that specializes and pioneers in real estate development for IT parks, Special Economic Zones (SEZs), Industrial Estates and malls, has..
on March 15, 2023 • NewsVoir
UGC NET December 2022 exam phase 3 city intimation slip released at ugcnet.nta.nic.in.
Credit: DNA - Published on February 28, 2023

The Phase 2 of the 17^th edition of BAJA SAEINDIA was hosted virtually from 16-18^th December 2022 at Chitkara University. In total 181 teams from various parts..
on December 19, 2022 • NewsVoir
*Salud Beverages*, an award-winning urban lifestyle brand introduced 11 uniquely designed Ethereum based NFTs - '*Salud Cusps*' in collaboration with Token..
on November 12, 2022 • NewsVoir
DU Merit List 2022: Delhi University is currently in Phase 3 of DU Admission 2022. Once the DU merit list is released, students will be able to view it on the..
Credit: Zee News - Published on October 19, 2022

DU Merit List 2022: Delhi University is currently in Phase 3 of DU Admission 2022. As per the schedule, the merit lists will be released today for UG Admissions..
Credit: Zee News - Published on October 18, 2022

For the DU Admissions 2022 Phase 3, the DU UG Merit list will be released on www.du.ac.in and the CSAS portal - www.admission.uod.ac.in.
Credit: DNA - Published on October 18, 2022

KEAM 2022 Final Allotment List for phase 3 for Engineering and Architecture is now available on the official website - cee.kerala.gov.in, scroll down for direct..
Credit: Zee News - Published on October 15, 2022

KEAM 2022 Final Allotment List for phase 3 for Engineering and Architecture is now available on the official website - cee.kerala.gov.in, scroll down for direct..
Credit: Zee News - Published on October 15, 2022

*Salud Beverages*, an award winning urban lifestyle brand has disrupted the market by introducing 9-11 uniquely designed Ethereum based NFTs which has already..
on October 12, 2022 • NewsVoir
Credit: newKerala.com - Published on October 11, 2022

Credit: newKerala.com - Published on October 5, 2022

UGC NET Phase 3 examination will be held on September 23, 29, 30, October 1, 8, 10, 11, 12, 13, and 14, 2022, scroll down for more details.
Credit: Zee News - Published on September 18, 2022

NTA UGC NET December 2021 phase 3 schedule has been released at nta.ac.in.
Credit: DNA - Published on September 17, 2022

TS DOST 2022: The exam conducting body will be releasing the TS DOST Counselling seat allotment results today for the 3rd round on the official website -..
Credit: Zee News - Published on September 16, 2022

TS DOST 2022: The exam conducting body will be releasing the TS DOST Counselling seat allotment results today for the 3rd round on the official website -..
Credit: Zee News - Published on September 16, 2022

RRB Group D Phase 3 E-call letter for examinations scheduled to be held from September 8 to September 19, 2022 have been released, scroll down for direct link to..
Credit: Zee News - Published on September 6, 2022

On August 23, 2022, Amgen announced positive top-line results from a phase 3 study of ABP 959, Amgen's proposed biosimilar to SOLIRIS.
Credit: Mondaq - Published on September 2, 2022

You might like